Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial

다국어 초록 (Multilingual Abstract)

Background: The use of newly developed mixed-dilution hemodiafiltration (HDF) can supplement the weaknesses of pre- and postdi- lution HDF. However, it is unclear whether mixed-HDF performs well compared to predilution HDF.
Methods: We conducted a prospective, open-labeled, randomized controlled trial from two hemodialysis centers in Korea. Between January 2017 and September 2019, 60 patients who underwent chronic hemodialysis were randomly assigned at a 1:1 ratio to re- ceive either predilution HDF (n = 30) or mixed-HDF (n = 30) for 6 months. We compared convection volume, changes in small- and medium-sized molecule clearance, high-sensitive C-reactive protein (hs-CRP) level, and dialysis-related parameters between the two dialysis modalities.
Results: A mean effective convection volume of 41.0 ± 10.3 L/session in the predilution HDF group and 51.5 ± 9.0 L/session in the mixed-HDF group was obtained by averaging values of three time-points. The difference in effective convection volume between the groups was 10.5 ± 1.3 L/session. This met the preset noninferiority criteria, suggesting that mixed-HDF was noninferior to predilution HDF. Moreover, the β2-microglobulin reduction rate was greater in the mixed-HDF group than in the predilution HDF group, while mixed-HDF provided greater transmembrane pressure. There were no significant between-group differences in Kt/V urea levels, changes in predialysis hs-CRP levels, proportions of overhydration, or blood pressure values. Symptomatic intradialytic hypotension episodes and other adverse events occurred similarly in the two groups.
Conclusion: Use of mixed-HDF was comparable to predilution HDF in terms of delivered convection volume and clinical parameters. Moreover, mixed-HDF provided better β2-microglobulin clearance than predilution HDF.

참고문헌 (Reference)

• 1 Sichart JM, "Utilization of hemodiafiltration as treatment modality in renal replacement therapy for end-stage renal disease patients : a global perspective" 175 : 163-169, 2011
• 2 Saran R, "US Renal Data System 2018 Annual Data Report : Epidemiology of Kidney Disease in the United States" 73 (73): A7-A8, 2019
• 3 Morena M, "Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly" 91 : 1495-1509, 2017
• 4 Pedrini LA, "Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss" 69 : 573-579, 2006
• 5 박경원, "The effect of on-line hemodiafiltration on heart rate variability in end-stage renal disease" 대한신장학회 32 (32): 127-133, 2013
• 6 Foster MC, "Serum β-trace protein and β2-microglobulin as predictors of ESRD, mortality, and cardiovascular disease in adults with CKD in the Chronic Renal Insufficiency Cohort(CRIC)study" 68 : 68-76, 2016
• 7 Kim ST, "Programmed filtration, a new method for removing large molecules and regulating albumin leakage during hemodiafiltration treatment" 38 (38): S220-S223, 2001
• 8 Kikuchi K, "Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis" 95 : 929-938, 2019
• 9 Canaud B, "Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration" 88 : 1108-1116, 2015
• 10 Helmut Schiffl, "Online hemodiafiltration and mortality risk in end-stage renal disease patients: A critical appraisal of current evidence" 대한신장학회 38 (38): 159-168, 2019
• 11 Tattersall JE, "Online haemodiafiltration : definition, dose quantification and safety revisited" 28 : 542-550, 2013
• 12 Pedrini LA, "On-line mixed hemodiafiltration with a feedback for ultrafiltration control : effect on middle-molecule removal" 64 : 1505-1513, 2003
• 13 Ahrenholz P, "On-line hemodiafiltration with pre-and postdilution : a comparison of efficacy" 20 : 81-90, 1997
• 14 Pedrini LA, "On-line hemodiafiltration : technique and efficiency" 16 (16): S57-S63, 2003
• 15 Canaud B, "On-line hemodiafiltra tion as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?" 22 (22): 40-48, 2004
• 16 Vaslaki L, "On-line haemodiafiltration versus haemodialysis : stable haematocrit with less erythropoietin and improvement of other relevant blood parameters" 24 : 163-173, 2006
• 17 Feliciani A, "New strategies in haemodi"afiltration(HDF) : prospective comparative analysis between on"line mixed HDF and mid-dilution HDF" 22 : 1672-1679, 2007
• 18 Jirka T, "Mortality risk for patients receiving hemodiafiltration versus hemodialysis" 70 : 1524-, 2006
• 19 Ok E, "Mortality and cardiovascular events in online haemodiafiltration(OL-HDF)compared with high-flux dialysis : results from the Turkish OL-HDF Study" 28 : 192-202, 2013
• 20 Pedrini LA, "Mixed-dilution hemodiafiltration" 158 : 123-130, 2007
• 21 Pedrini LA, "Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes" 58 : 2155-2165, 2000
• 22 Maduell F, "High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients" 24 : 487-497, 2013
• 23 Canaud B, "Hemodiafiltration to address unmet medical needs ESKD patients" 13 : 1435-1443, 2018
• 24 Fournier A, "Factors associated with albumin loss in post-dilution hemodiafiltration and nutritional consequences" 38 : 76-82, 2015
• 25 Masakane I, "Evidence for the clinical advantages of predilution on-line hemodiafiltration" 189 : 17-23, 2017
• 26 Wizemann V, "Efficacy of haemodiafiltration" 16 (16): 27-30, 2001
• 27 이유호, "Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients" 대한신장학회 39 (39): 103-111, 2020
• 28 Pedrini LA, "Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients" 14 : e0212795-, 2019
• 29 Wang AY, "Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure : a systematic review and meta-analysis of randomized trials" 63 : 968-978, 2014
• 30 Masakane I, "Current approaches to middle molecule removal : room for innovation" 33 (33): iii12-iii21, 2018
• 31 Potier J, "Clinical performance assessment of CorDiax filters in hemodialysis and hemodiafiltration" 189 : 237-245, 2017
• 32 Akizawa T, "Clinical expectation of online hemodiafiltration : a Japanese perspective" 40 (40): 12-16, 2015
• 33 Blankestijn PJ, "Clinical evidence on haemodiafiltration" 33 (33): iii53-iii58, 2018
• 34 Tsuchida K, "Clinical benefits of predilution on-line hemodiafiltration" 35 (35): 18-22, 2013
• 35 Cuvelier C, "Albumin losses during hemodiafiltration : all dialyzers are not created equal-a case report" 20 : 392-, 2019
• 36 de Sequera P, "A comparison of the effectiveness of two online haemodiafiltration modalities : mixed versus post-dilution" 33 : 779-787, 2013